Thinking of taking your company public? Get our essential guide to a successful IPO. Download Now

Westicke Partners


Mike Piccinino, CFA

Mike has been exclusively focused on advising MedTech & Diagnostics companies since he joined the firm in early 2011. As a member of ICR Westwicke’s MedTech & Diagnostics team, Mike has established strong relationships with both private, and public, clients, in a variety of therapeutic and device areas.


Mike Piccinino

These therapeutic and device areas include: Alliqua BioMedical, Applied Proteomics, APYX Medical, Avedro, Baebies, Bioventus, Bovie Medical, ConforMIS, GI Dynamics, Greatbatch, Halyard Health, Hansen Medical, Helius Medical Technologies, Hologic, Humacyte, Kinetic Concepts, K2M Group Holdings, Lumenis, Mauna Kea Technologies, Merit Medical, Organogenesis, Preventice Solutions, Rochester Medical, Senseonics, Strand Life Sciences, Synergetics, Tactile Medical, Teleflex, Urologix, Venaxis, Venus Concepts and Vicarious Surgical.

Prior to joining ICR Westwicke, Mike worked as an equity research analyst at T. Rowe Price in Baltimore, Maryland and, in this role, worked closely with small-cap mutual fund portfolio managers, providing industry knowledge and stock recommendations appropriate to each fund’s focus. During his nine years with T. Rowe Price, Mike was involved in all facets of the buy-side investment process for companies across multiple sectors and market capitalization ranges. His responsibilities as an equity research analyst included evaluating new investment opportunities, monitoring existing holdings, valuation analysis, engaging with bankers, analysts and management teams at conferences and industry events. Mike also evaluated transaction-based investment opportunities including M&A events and equity offerings, including IPOs, PIPEs and follow-ons. Mike also spent a year in T. Rowe Price’s Global Investment Services group working on the institutional sales and client service team.

Mike holds a BA from James Madison University and received his Chartered Financial Analyst designation in 2006. Mike also holds a Series 79 securities license and earned the Investor Relations Charter (IRC®) credential in 2018. Mike lives in Ellicott City, Maryland with his wife, Brandi, and daughters, Whitney and Charlotte.

Read blog posts by Mike Piccinino >>

Have News to Release?

Find out whether you should file a Form 8-K, issue a press release, or do both by using our easy-to-reference chart, “Form 8K vs. Press Release: What’s the Difference?

Our Locations